LGMN and neoplasm: In addition, the inhibitory effect of an isolated carbohydrate fraction of AndoSanTM [15] on the tissue degrading pro-inflammatory and tumor-associated enzyme, legumain (aspariginyl endopeptidase), that probably may also contribute to less inflammatory activity in the CD patients.